about
Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia.Communication between the cell membrane and the nucleus: role of protein compartmentalization.Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The bcr-abl gene in chronic myelogenous leukaemia.
@ast
The bcr-abl gene in chronic myelogenous leukaemia.
@en
type
label
The bcr-abl gene in chronic myelogenous leukaemia.
@ast
The bcr-abl gene in chronic myelogenous leukaemia.
@en
prefLabel
The bcr-abl gene in chronic myelogenous leukaemia.
@ast
The bcr-abl gene in chronic myelogenous leukaemia.
@en
P1433
P1476
The bcr-abl gene in chronic myelogenous leukaemia.
@en
P2093
Sawyers CL
P577
1992-01-01T00:00:00Z